Exor N.V. (0RKY.IL)
| Previous close | 101.38 |
| Open | 101.00 |
| Bid | 94.95 x 0 |
| Ask | 104.90 x 0 |
| Day's range | 99.50 - 101.30 |
| 52-week range | 73.24 - 105.20 |
| Volume | |
| Avg. volume | 62,687 |
| Market cap | 35.662B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 6.37 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.44 (0.53%) |
| Ex-dividend date | 02 Jun 2023 |
| 1y target est | N/A |
- GlobeNewswire
Exor Press Release - Restart of Announced Share Buyback Program
Amsterdam, 15 April 2024 EXOR N.V. ANNOUNCES THE RESTART OF THE ANNOUNCED SHARE BUYBACK PROGRAM Exor N.V. (the “Company”) announces today that it will restart the share buyback program announced on 13 September 2023 (the “Program”) for the remaining amount of up to € 250 million of ordinary shares to reduce Exor’s share capital in line with the announcement made on 13 September 2023. The Company will start on 15 April 2024 with a first tranche of purchases up to €125 million, which is expected t
- GlobeNewswire
Exor Press Release - FY2023 Results
Amsterdam, 11 April 2024 EXOR DELIVERS 33% GROWTH IN NAV PER SHARE IN 2023 NAV reached €35.5 billion at 31 December 2023 with NAV per share increasing by 32.7%, outperforming the MSCI World Index by 15.1 p.p. This increase was mainly driven by the share price performance of Ferrari and Stellantis.Portfolio diversification increased after the PartnerRe sale, with €5.4 billion cash deployed in 2023 into Companies, Investments and share buybacks, while maintaining a strong balance sheet with an LTV
- GlobeNewswire
Clarivate and Exor sign agreement
Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company’s Board of Directors Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the Company’s Management and Board, and announces it now has a 10.1% shareholding in the Company and can increase its participation up to 17.5% London, U.K., and Amsterdam, the Netherlands, March 4, 2024 – Clarivate Plc (NYSE: CLVT), a leading global provider of transf
